Cutera (CUTR) Stock Forecast, Price & News

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CUTR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CUTR, but not buy additional shares or sell existing shares.
View CUTR analyst ratings or view top-rated stocks.

5 equities research analysts have issued twelve-month price objectives for Cutera's stock. Their CUTR share price forecasts range from $14.00 to $50.00. On average, they anticipate the company's stock price to reach $32.75 in the next twelve months. This suggests a possible upside of 91.0% from the stock's current price.
View analysts price targets for CUTR or view top-rated stocks among Wall Street analysts.

Cutera's stock was trading at $44.22 at the start of the year. Since then, CUTR shares have decreased by 61.2% and is now trading at $17.15.
View the best growth stocks for 2023 here.

Cutera saw a increase in short interest in May. As of May 15th, there was short interest totaling 4,460,000 shares, an increase of 6.7% from the April 30th total of 4,180,000 shares. Based on an average daily volume of 817,600 shares, the short-interest ratio is presently 5.5 days.
View Cutera's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our CUTR earnings forecast.

Cutera, Inc. (NASDAQ:CUTR) announced its earnings results on Tuesday, May, 9th. The medical device company reported ($1.26) EPS for the quarter, missing the consensus estimate of ($0.30) by $0.96. The medical device company earned $55 million during the quarter, compared to analyst estimates of $59.80 million. Cutera had a negative trailing twelve-month return on equity of 489.05% and a negative net margin of 36.98%. The business's revenue was down 5.2% on a year-over-year basis. During the same period last year, the firm posted ($0.84) earnings per share.

ETFs with the largest weight of Cutera (NASDAQ:CUTR) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), ALPS Disruptive Technologies ETF (DTEC), Invesco S&P SmallCap Health Care ETF (PSCH), Invesco DWA SmallCap Momentum ETF (DWAS), Principal Healthcare Innovators ETF (BTEC),

1 employees have rated Cutera Chief Executive Officer David H. Mowry on Glassdoor.com. David H. Mowry has an approval rating of 100% among the company's employees. This puts David H. Mowry in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include NVIDIA (NVDA), QUALCOMM (QCOM), AbbVie (ABBV), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), DocuSign (DOCU), Pfizer (PFE), Block (SQ) and Twilio (TWLO).

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

Cutera's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (13.86%), RTW Investments LP (9.31%), FMR LLC (7.35%), Gamco Investors INC. ET AL (5.68%), State Street Corp (4.03%) and First Light Asset Management LLC (2.87%). Insiders that own company stock include David H Mowry, J Daniel Plants, Joseph E Whitters, Katherine S Zanotti, Rohan Seth and Timothy J Oshea.
View institutional ownership trends.

Shares of CUTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CUTR stock can currently be purchased for approximately $17.15.

Cutera (NASDAQ:CUTR) has a market capitalization of $340.08 million and generates $252.40 million in revenue each year. The medical device company earns $-82,340,000.00 in net income (profit) each year or ($4.81) on an earnings per share basis.

The company employs 461 workers across the globe.

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The official website for the company is www.cutera.com. The medical device company can be reached via phone at (415) 657-5500, via email at ir@cutera.com, or via fax at 415-330-2444.